.png){kind=logo}
If work performed for you at the San Diego CFAR Translational Virology Core results in publication, please acknowledge us with the following statement and please e-mail a PDF of your publication to the Core Administrator:
Faculty and Staff of the Translational Virology Core please use the following acknowledgement statement for our publications:
This work was supported by the Department of Veterans Affairs and grants from the National Institutes of Health: DA047039 (R61 Smith - Opioid Impacts), AI120009 (R01 Smith-P3 deep sequencing tech), AI131385 (P01 Smith-R3 Last Gift, Early Treatment interruption), AI100665 (Smith-K24Training), DA041007 (Smith-SMRT Brain TaPHR), AI118422 (Smith-Perturb Immune Stimulation), AI036214 (Smith-CFAR), AI007384 (Richman/Guatelli-T32 Training), AI126619 (Richman-CARE 2 Delaney), AI126620 (Richman-BEAT Delaney), MH062512 (Heaton-HNRC), MH107345 (Heaton/Letendre-HAND-Age-related), AI106039 (Little-PIRC), AI104283 (Strain-R33), DA037811 (Patterson-Tijuana), AI147821 (Gianella-CMV Replication on HIV Persistence), DA051915 (Gianella-Avenir), AI134295 (Gianella-Sex Hormones & Persistence), HD094646 (Gianella-Declining Sex Hormones), AI027763 (Gianella Supplement-CMV driven mechanisms). The following grants also contributed support: OPP115400 (Richman-Gates), ID15-SD-063 (Gianella-CHRP); The James B. Pendleton Charitable Trust.